Therapeutic effectiveness of biosimilar standard interferon versus pegylated interferon for chronic hepatitis C genotypes 2 or 3

BACKGROUND: Pegylated interferon (Peg-IFN) and standard interferon (IFN) play a significant role in the treatment of hepatitis C virus (HCV) infection. Biosimilar standard IFN is widely available in Brazil for the treatment of HCV infection genotypes 2 or 3, but its efficacy compared to Peg-IFN is u...

Полное описание

Библиографические подробности

Главные авторы:	Aline Gonzalez Vigani, Eduardo Sellan Gonçales, Maria Helena Postal Pavan, Flavia Genari, Raquel Tozzo, Maria Silvia Kroll Lazarini, Viviane Fais, Adriana Feltrin, Neiva Sellan Gonçales, Fernando Lopes Gonçales Jr
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier
Серии:	Brazilian Journal of Infectious Diseases
Предметы:	interferons hepatitis C treatment outcome
Online-ссылка:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000300003&lng=en&tlng=en
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!